News

Sam Altman is reportedly entering in brain-computer interface domain through a new startup, Merge Labs. The company is ...
Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting brain cells. Read more here.
OpenAI is reportedly discussing a potential investment in a new startup that aims to compete with Elon Musk’s brain implant ...
The Financial Times reports today that OpenAI co-founder Sam Altman plans to invest in new brain-computer interface (BCI) venture Merge Labs.
The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify ...
Merge Labs is a new Neuralink rival developing brain-computer interfaces. If you’ve enjoyed Elon Musk’s ongoing beef with ...
OpenAI CEO Sam Altman is in talks to co-found Merge Labs, a potential $850M brain–computer interface startup rivaling Elon ...
Microsoft (NASDAQ:MSFT)-backed OpenAI co-founder Sam Altman is gearing up to back Merge Labs, a new brain-computer interface startup that could go head-to-head with Elon Musk's Neuralink, the ...